Target intelligence / Profile preview

Nerve growth factor receptor mRNA 3' untranslated region (NGFR mRNA 3'UTR)

Target
NGFR mRNA 3'UTR
Molecular classification
RNA, Untranslated region, Regulatory element
01

Overview

The Nerve growth factor receptor (NGFR) mRNA 3' untranslated region (3'UTR) is a critical regulatory sequence located at the 3' end of the NGFR transcript, which encodes the p75 neurotrophin receptor (p75NTR). This region serves as a hub for post-transcriptional regulation, containing various cis-acting elements such as AU-rich elements and microRNA (miRNA) binding sites that control mRNA stability and translation (NCBI Gene, 2023). In diseases like melanoma, the 3'UTR is often targeted by oncogenic miRNAs to modulate p75NTR levels, which influences tumor cell plasticity and metastasis (PubMed, PMID: 31254052). In neurodegenerative contexts, such as Alzheimer's disease, the regulation of NGFR mRNA stability via its 3'UTR is vital for determining neuronal survival or apoptosis (UniProt, P08138). Therapeutic strategies targeting this region include antisense oligonucleotides (ASOs) and miRNA mimics designed to downregulate p75NTR expression in pathological states. These RNA-targeted approaches aim to provide high specificity by exploiting the unique sequence of the NGFR 3'UTR to treat conditions characterized by p75NTR dysregulation.

Other names
p75NTR mRNA 3'UTRTNFRSF16 mRNA 3'UTRCD271 mRNA 3'UTRLow-affinity nerve growth factor receptor mRNA 3'UTRp75 neurotrophin receptor mRNA 3'UTR
02

Mechanism of action

RNase H-mediated mRNA degradation, RNA interference (RNAi), and steric hindrance of RNA-binding protein interactions to modulate p75NTR protein expression.

03

Biological functions

Post-transcriptional gene regulationmRNA stability controlTranslation inhibitionmRNA localizationRegulation of apoptosisCell signaling modulation
04

Disease associations

MelanomaAlzheimer's diseaseNerve injuryAmyotrophic lateral sclerosis (ALS)Neurodegenerative diseaseCancer metastasis
05

Safety considerations

Off-target RNA binding and hybridization-dependent toxicityInnate immune activation by synthetic oligonucleotidesPotential for unintended disruption of neurotrophin signaling in healthy neuronsSystemic delivery challenges to the central nervous system
06

Interacting drugs

Antisense oligonucleotides (experimental)

2 more in the full profile.

07

Biomarkers

NGFR mRNA expression levelsp75NTR protein expression (CD271)Circulating microRNA levels (e.g., miR-21, miR-124)

Beyond the preview

Go deeper on Nerve growth factor receptor mRNA 3' untranslated region (NGFR mRNA 3'UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nerve growth factor receptor mRNA 3' untranslated region (NGFR mRNA 3'UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call